Xinlai Cheng

1.8k total citations
57 papers, 1.4k citations indexed

About

Xinlai Cheng is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Xinlai Cheng has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 14 papers in Organic Chemistry and 11 papers in Oncology. Recurrent topics in Xinlai Cheng's work include Quinazolinone synthesis and applications (11 papers), CRISPR and Genetic Engineering (8 papers) and Synthesis and Biological Evaluation (6 papers). Xinlai Cheng is often cited by papers focused on Quinazolinone synthesis and applications (11 papers), CRISPR and Genetic Engineering (8 papers) and Synthesis and Biological Evaluation (6 papers). Xinlai Cheng collaborates with scholars based in Germany, China and Egypt. Xinlai Cheng's co-authors include Stefan Wölfl, Gerhard Eisenbrand, Karl‐Heinz Merz, Michaël Wink, Ingo Ott, Hamed Alborzinia, D. M. Schaefer, Jannick Theobald, Shan Su and Riccardo Rubbiani and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

Xinlai Cheng

57 papers receiving 1.4k citations

Peers

Xinlai Cheng
Manu Lopus India
Purusottam Mohapatra India
Karol Bukowski Poland
Ming Ji China
Suresh Thareja India
Amir Faisal Pakistan
Shakti Ranjan Satapathy India
Yi‐Ru Chen Taiwan
Bing Zhu China
Kaisheng Liu China
Manu Lopus India
Xinlai Cheng
Citations per year, relative to Xinlai Cheng Xinlai Cheng (= 1×) peers Manu Lopus

Countries citing papers authored by Xinlai Cheng

Since Specialization
Citations

This map shows the geographic impact of Xinlai Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinlai Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinlai Cheng more than expected).

Fields of papers citing papers by Xinlai Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinlai Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinlai Cheng. The network helps show where Xinlai Cheng may publish in the future.

Co-authorship network of co-authors of Xinlai Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xinlai Cheng. A scholar is included among the top collaborators of Xinlai Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinlai Cheng. Xinlai Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jianhui, Zhigang Bai, T. Hüfner, et al.. (2025). A Chemically Induced CRISPR/dCas13 FCPF Platform for Precise and Programmable RNA Regulation. Journal of Medicinal Chemistry. 68(21). 22633–22649. 1 indexed citations
2.
Wang, Jianhui, Marcel Heinz, Kang Han, et al.. (2024). Thalidomide derivatives degrade BCL-2 by reprogramming the binding surface of CRBN. Cell Reports Physical Science. 5(5). 101960–101960. 9 indexed citations
3.
Kang, Han Chang, Ralf Mrowka, Jochen Utikal, et al.. (2023). Development of a next-generation endogenous OCT4 inducer and its anti-aging effect in vivo. European Journal of Medicinal Chemistry. 257. 115513–115513. 6 indexed citations
4.
Chen, Jie, Georg Tascher, Václav Němec, et al.. (2021). A Chemical Toolbox for Labeling and Degrading Engineered Cas Proteins. SHILAP Revista de lepidopterología. 1(6). 777–785. 16 indexed citations
5.
Ma, Danhui, Heming Wang, Jiayi Wei, et al.. (2021). Baicalein Induces Apoptosis of Pancreatic Cancer Cells by Regulating the Expression of miR-139-3p and miR-196b-5p. Frontiers in Oncology. 11. 653061–653061. 31 indexed citations
6.
Chen, Jie, et al.. (2021). A PROTAC targets splicing factor 3B1. Cell chemical biology. 28(11). 1616–1627.e8. 22 indexed citations
7.
Cheng, Xinlai. (2020). Valproic Acid Thermally Destabilizes and Inhibits SpyCas9 Activity. Molecular Therapy. 28(12). 2635–2641. 10 indexed citations
8.
Yao, Qunyan, Shuyu Li, Xinlai Cheng, et al.. (2020). Yin Zhi Huang, a traditional Chinese herbal formula, ameliorates diet-induced obesity and hepatic steatosis by activating the AMPK/SREBP-1 and the AMPK/ACC/CPT1A pathways. Annals of Translational Medicine. 8(5). 231–231. 28 indexed citations
9.
Maaty, Mohamed A. Abu el, et al.. (2019). p53-Dependent Anti-Proliferative and Pro-Apoptotic Effects of a Gold(I) N-Heterocyclic Carbene (NHC) Complex in Colorectal Cancer Cells. Frontiers in Oncology. 9. 438–438. 36 indexed citations
10.
Li, Hanmei, et al.. (2019). Pro-oxidant and lifespan extension effects of caffeine and related methylxanthines in Caenorhabditis elegans. Food Chemistry X. 1. 100005–100005. 41 indexed citations
11.
Theobald, Jannick, et al.. (2018). A Ruthenium(II) N-Heterocyclic Carbene (NHC) Complex with Naphthalimide Ligand Triggers Apoptosis in Colorectal Cancer Cells via Activating the ROS-p38 MAPK Pathway. International Journal of Molecular Sciences. 19(12). 3964–3964. 29 indexed citations
12.
Theobald, Jannick, Xinlai Cheng, H Gaitantzi, et al.. (2017). Monitoring cytochrome P450 activity in living hepatocytes by chromogenic substrates in response to drug treatment or during cell maturation. Archives of Toxicology. 92(3). 1133–1149. 3 indexed citations
13.
Cheng, Xinlai & Karl‐Heinz Merz. (2016). The Role of Indirubins in Inflammation and Associated Tumorigenesis. Advances in experimental medicine and biology. 929. 269–290. 20 indexed citations
14.
Cheng, Xinlai, et al.. (2016). Modified STAP conditions facilitate bivalent fate decision between pluripotency and apoptosis in Jurkat T-lymphocytes. Biochemical and Biophysical Research Communications. 472(4). 585–591. 2 indexed citations
15.
Su, Shan, Xinlai Cheng, & Michaël Wink. (2015). Natural lignans from Arctium lappa modulate P-glycoprotein efflux function in multidrug resistant cancer cells. Phytomedicine. 22(2). 301–307. 47 indexed citations
16.
Cheng, Xinlai, Suzan Can, Hamed Alborzinia, et al.. (2014). A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells. Molecular Cancer. 13(1). 221–221. 98 indexed citations
17.
Wagner, Bjoern, et al.. (2013). Physicochemical characterization and in vitro permeation of an indirubin derivative. European Journal of Pharmaceutical Sciences. 50(3-4). 467–475. 13 indexed citations
18.
Cheng, Xinlai, Hamed Alborzinia, Karl‐Heinz Merz, et al.. (2012). Indirubin Derivatives Modulate TGFβ/BMP Signaling at Different Levels and Trigger Ubiquitin-Mediated Depletion of Nonactivated R-Smads. Chemistry & Biology. 19(11). 1423–1436. 32 indexed citations
19.
Nam, Sangkil, Anna Scuto, Fan Yang, et al.. (2012). Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling. Molecular Oncology. 6(3). 276–283. 59 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manu Lopus Breakdown of academic impact, for papers by Purusottam Mohapatra Breakdown of academic impact, for papers by Karol Bukowski Breakdown of academic impact, for papers by Ming Ji Breakdown of academic impact, for papers by Suresh Thareja Breakdown of academic impact, for papers by Amir Faisal Breakdown of academic impact, for papers by Shakti Ranjan Satapathy Breakdown of academic impact, for papers by Yi‐Ru Chen Breakdown of academic impact, for papers by Bing Zhu Breakdown of academic impact, for papers by Kaisheng Liu
Rankless by CCL
2026